CardioSert Ltd.
Industry
- Medical Devices
- Surgical Equipment & Devices
See more in Biomedtracker
Latest on CardioSert Ltd.
Medtech Insight
• By Marion Webb
Microbot Medical Inc. expects its Liberty system to be the first company to introduce a fully disposable endovascular robotic system in the US in 2023, but still has a long regulatory pathway ahead.
In Vivo
• By Marion Webb
Microbot Medical Inc. expects its Liberty system to be the first company to introduce a fully disposable endovascular robotic system in the US in 2023, but still has a long regulatory pathway ahead.
In Vivo
• By Beth Allan, Deanna Kamienski, and Maureen Riordan
IN VITRO DIAGNOSTICS Financings HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics Inc. netted $37.9mm through a public offering of 13.9mm common shares (including the overallotment) at $2.9